Sandbox:Aneeza: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m added the overview of the topic |
||
| Line 1: | Line 1: | ||
===={{CMG}}; {{AE}} {{Aneeza Jamshed}}==== | ===={{CMG}}; {{AE}} {{Aneeza Jamshed}}==== | ||
| Line 8: | Line 4: | ||
===OVERVIEW:=== | ===OVERVIEW:=== | ||
Libman-sack endocarditis is the | Libman-sack endocarditis is the one of the cardiac manifestations of autoimmune systemic diseases most commonly [[Systemic lupus erythematosus|Systemic Lupus Erythematosus]]. It may also be a finding in malignancy with the non-bacterial non-thrombotic involvement of the valves, most commonly the aortic and mitral valve. The most common complications include embolic phenomenon like cerebrovascular disease. The disease activity and titer of the antibodies in Systemic Lupus Erythematosus can be linked to Libman-sack Endocarditis<ref name="pmidPMID: 20422938">{{cite journal| author=Carrillo-Esper R, Carrillo-Córdova JR, Carrillo-Córdova LD, Carrillo-Córdova CA| title=[Libman-Sacks endocarditis]. | journal=Gac Med Mex | year= 2010 | volume= 146 | issue= 1 | pages= 67-9 | pmid=PMID: 20422938 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20422938 }} </ref>. | ||
< | |||
. | |||
=<nowiki>=</nowiki>= | =<nowiki>=</nowiki>= | ||
Revision as of 11:34, 4 April 2021
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aneeza Jamshed, M.B.B.S.[2]
LIBMAN-SACK ENDOCARDITIS:
OVERVIEW:
Libman-sack endocarditis is the one of the cardiac manifestations of autoimmune systemic diseases most commonly Systemic Lupus Erythematosus. It may also be a finding in malignancy with the non-bacterial non-thrombotic involvement of the valves, most commonly the aortic and mitral valve. The most common complications include embolic phenomenon like cerebrovascular disease. The disease activity and titer of the antibodies in Systemic Lupus Erythematosus can be linked to Libman-sack Endocarditis[1].
=
[2] ===
| Criteria | Symptomatic WM | Asymptomatic WM | IgM-Related Disorders | MGUS |
|---|---|---|---|---|
| IgM monoclonal protein | + | + | + | + |
| Bone marrow infiltration | + | + | - | - |
| Symptoms attributable to IgM | + | - | + | - |
| Symptoms attributable to tumor infiltration | + | - | - | - |
|
Libman-Sacks endocarditis Microchapters |
|
Differentiating Libman-Sacks Endocarditis from other Diseases |
|---|
Reference
- ↑ Carrillo-Esper R, Carrillo-Córdova JR, Carrillo-Córdova LD, Carrillo-Córdova CA (2010). "[Libman-Sacks endocarditis]". Gac Med Mex. 146 (1): 67–9. PMID 20422938 PMID: 20422938 Check
|pmid=value (help). - ↑ Mao Y, Yang D, He J, Krasna MJ (2016). "Epidemiology of Lung Cancer". Surg Oncol Clin N Am. 25 (3): 439–45. doi:10.1016/j.soc.2016.02.001. PMID 27261907.